Brain support

Technical data
Clinical studies

ZINCNOVA™ is a novel encapsulated zinc oxide for fortifying applications with:

  • controlled interactions with other compounds
  • reduced metallic taste and
  • easy to incorporate.

Contributes to normal function of the immune system, normal cognitive function, and maintenance of normal bone and normal vision.


  • No grainy textureZincnova LQ_002

The microcapsule structure of ZINCNOVA™ was determined by Scanning Electron Microscopy. The spherical geometry of ZINCNOVA™ deminished the contact surface, minimising the grainy texture of the fortifying agent in the mouth.

  • Tasteless 

A panel of 8 volunteers tasted a commercial milk fortified with 0,1 mg/mL ZINCNOVA™. The non-enriched milk was used as a control. The taste of the milk with ZINCNOVA™ did not show any remarkable difference respect to the non-fortified one.

  • No color change

An orange juice was fortified with 0,1mg/mL ZINCNOVA™ or non-encapsulated zinc oxide. The same commercial juice was used as a control. The samples were homogenised and pasteurised and the change in colour was controlled by a colorimeter. The colour of the juice containing ZINCNOVA™ was similar to that of the commercial juice.

  • Effective release in stomach

In order to study the availability of the zinc after the digestion in the stomach, 0,1 mg/mL ZINCNOVA™ was added in a simulated gastric fluid (ph 1,2-1,5) with and without pepsin for 2 hours. Samples were taken every 30 min to study the kinetics of release of the active ingredient. It was liberated more than 75% of Zn2+ after 90 minutes. In presence of pepsin, the release effectively increased to 80% and 100% after 1 and 2 hours.


Technical data


ZINCNOVA™ powder is standardized to contain 20% of zinc.

Composition: Mono- and Diglycerides Fatty Acids (E471), Zinc Oxide.

Recommended use and dose:

The Recommended Daily Allowance (RDA) in the European Union is 10 mg.


Suitable for food supplements and foods such as: daily products, cereals, nutritional bars, confectionery, etc.

Clinical studies
  • Zinc contributes to normal function of immune system

It was reported that the activity of thymulin (thymus-specific hormone, it requires the presence of zinc for its biological activity to be expressed) in serum was decreased significantly and was corrected both In vivo and In vitro zinc supplementation as a result of mild deficiency of zinc in humans.

  • Zinc helps to  the maintenance of normal bone

Osteoporotic patients have  been shown to have lower levels of skeletal zinc than healthy individuals. Intake of dietary zinc may have a beneficial effect in the prevention of osteoporosis, and childhood is the best time to form the lifestyle behaviours that promote optimal bone health. In this respect, osteoporosis is recognised today to be a ´´pediatric disease with geriatric consequences´´.

  • Zinc aids to normal cognitive function

Some studies provide evidence that zinc deficiency contributes to compromised neurobehavioural function among infants and children. In a zinc supplementation trial among infants in rural Guatemala, their activity patterns were improved with zinc supplementation.

Another study among one year-old Indian children indicated that supplemental zinc plus vitamins resulted in higher activity levels that vitamins alone.

Furthermore, school-aged children in China demonstrated improved neuropshychologic test performance with supplemental zinc.

  • Zinc contributes to the maintenance of normal vision

Zinc may also serve a critical function as an antioxidant in the retina. The photoreceptors are particularly susceptible to oxidative damage because of their high metabolic rate and constant bombardment by light. The retina also has relatively low peroxide scavenging capabilities.